EFNS guideline on the management of status epilepticus

The objective of the current paper was to review the literature and discuss the degree of evidence for various treatment strategies for status epilepticus (SE) in adults. We searched MEDLINE and EMBASE for relevant literature from 1966 to January 2005. Furthermore, the Cochrane Central Register of Controlled Trials (CENTRAL) was sought. Recommendations are based on this literature and on our judgement of the relevance of the references to the subject. Recommendations were reached by informative consensus approach. Where there was a lack of evidence but consensus was clear we have stated our opinion as good practice points. The preferred treatment pathway for generalised convulsive status epilepticus (GCSE) is intravenous (i.v.) administration of 4 mg of lorazepam or 10 mg of diazepam directly followed by 15–18 mg/kg of phenytoin or equivalent fosphenytoin. If seizures continue for more than 10 min after first injection another 4 mg of lorazepam or 10 mg of diazepam is recommended. Refractory GCSE is treated by anaesthetic doses of midazolam, propofol or barbiturates; the anaesthetics are titrated against an electroencephalogram burst suppression pattern for at least 24 h. The initial therapy of non‐convulsive SE depends on the type and the cause. In most cases of absence SE, a small i.v. dose of lorazepam or diazepam will terminate the attack. Complex partial SE is initially treated such as GCSE, however, when refractory further non‐anaesthetising substances should be given instead of anaesthetics. In subtle SE i.v. anaesthesia is required.

[1]  E. Bromfield,et al.  Efficacy of rapid IV administration of valproic acid for status epilepticus , 2005, Neurology.

[2]  M. Holtkamp,et al.  Transient loss of inhibition precedes spontaneous seizures after experimental status epilepticus , 2005, Neurobiology of Disease.

[3]  M. Holtkamp,et al.  Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  M. Brainin,et al.  Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004 * , 2004, European journal of neurology.

[5]  N. Fountain,et al.  Assessment of acute morbidity and mortality in nonconvulsive status epilepticus , 2003, Neurology.

[6]  K. Einhäupl,et al.  The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists , 2003, Journal of neurology, neurosurgery, and psychiatry.

[7]  Jan Claassen,et al.  Treatment of status epilepticus: a survey of neurologists , 2003, Journal of the Neurological Sciences.

[8]  C. Tonon,et al.  Incidence and Short‐term Prognosis of Status Epilepticus in Adults in Bologna, Italy , 2003, Epilepsia.

[9]  R. Macdonald,et al.  GABA(A) receptor function and pharmacology in epilepsy and status epilepticus. , 2003, Current opinion in pharmacology.

[10]  P. Garcia,et al.  Incidence and mortality of generalized convulsive status epilepticus in California , 2002, Neurology.

[11]  Jan Claassen,et al.  Refractory status epilepticus: frequency, risk factors, and impact on outcome. , 2002, Archives of neurology.

[12]  Jan Claassen,et al.  Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic Review , 2002, Epilepsia.

[13]  J. Mazur,et al.  Intravenous Valproate in Status Epilepticus , 2001, The Annals of pharmacotherapy.

[14]  M R Segal,et al.  A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. , 2001, The New England journal of medicine.

[15]  W. Oertel,et al.  Incidence of Status Epilepticus in Adults in Germany: A Prospective, Population‐Based Study , 2001, Epilepsia.

[16]  Reuel Shinnar,et al.  How long do new‐onset seizures in children last? , 2001, Annals of neurology.

[17]  E. Bertram,et al.  Propofol and Midazolam in the Treatment of Refractory Status Epilepticus , 2001, Epilepsia.

[18]  P. Kaplan,et al.  No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: « The cure may be worse than the disease ») , 2000, Neurophysiologie Clinique/Clinical Neurophysiology.

[19]  D. Naritoku,et al.  Intravenous valproate is well tolerated in unstable patients with status epilepticus , 2000, Neurology.

[20]  P Jallon,et al.  Incidence of status epilepticus in French-speaking Switzerland , 2000, Neurology.

[21]  T. Babb,et al.  Epileptogenicity Correlated with Increased N‐Methyl‐d‐Aspartate Receptor Subunit NR2A/B in Human Focal Cortical Dysplasia , 2000, Epilepsia.

[22]  N. Fountain Status Epilepticus: Risk Factors and Complications , 2000, Epilepsia.

[23]  J. Wheless,et al.  Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients , 1999, Epilepsy Research.

[24]  M. Walker,et al.  Halothane as a Neuroprotectant During Constant Stimulation of the Perforant Path , 1999, Epilepsia.

[25]  D. Lowenstein,et al.  It's Time to Revise the Definition of Status Epilepticus , 1999, Epilepsia.

[26]  D. Hanley,et al.  Use of midazolam in the treatment of refractory status epilepticus. , 1998, Clinical therapeutics.

[27]  B. Uthman,et al.  A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. , 1998, The New England journal of medicine.

[28]  M. Stecker,et al.  Treatment of Refractory Status Epilepticus with Propofol: Clinical and Pharmacokinetic Findings , 1998, Epilepsia.

[29]  R. Macdonald,et al.  Rapid Seizure-Induced Reduction of Benzodiazepine and Zn2+ Sensitivity of Hippocampal Dentate Granule Cell GABAA Receptors , 1997, The Journal of Neuroscience.

[30]  G. Cascino Generalized convulsive status epilepticus. , 1996, Mayo Clinic proceedings.

[31]  O. Snead,et al.  Basic mechanisms of generalized absence seizures , 1995, Annals of neurology.

[32]  M. C. McBride,et al.  Status epilepticus. , 2016, Pediatrics in review.

[33]  S. Shorvon Status Epilepticus: Its Clinical Features and Treatment in Children and Adults , 1994 .

[34]  W H Theodore,et al.  The secondarily generalized tonic‐clonic seizure , 1994, Neurology.

[35]  R. Delorenzo,et al.  Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. , 1993, JAMA.

[36]  R. Ramsay,et al.  Double-blind study of lorazepam and diazepam in status epilepticus. , 1983, JAMA.

[37]  P. Kellaway,et al.  Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures , 1981, Epilepsia.

[38]  B. Meldrum,et al.  Physiology of status epilepticus in primates. , 1973, Archives of neurology.